People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Element Genomics, Inc. | — | Biotech | Series A | $4.8M | $175.3M | 2016 |
Charles A. Gersbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles A. Gersbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Oxaal | 1 | 7 |
| Timothy E. Reddy | 1 | 1 |
| Gregory E. Crawford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.